Medicines in Development for Antimicrobial Resistance (AMR) 2021 Report

  03 May 2021

As the world confronts the COVID-19 public health crisis, now more than ever is the time to consider preparedness for a growing public health threat: antimicrobial resistance (AMR). AMR is a natural process that occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that make the medicines used to treat the infections they cause ineffective. Therefore, the more we use such medicines, the more resistance we may create. This means a robust and sustained pipeline of new and novel antimicrobial medicines is critical to ensure that new innovations and interventions can keep pace with these evolving pathogens.

Further reading: PhRMA
Author(s): PhRMA
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

Evotec

JSS University

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS





Global Ambassador Network

Welcome at the AMR Insights Ambassador Network!

The AMR Insights Ambassador Network is a growing, distinctive group of professionals who stand out for their commitment, willingness to cooperate and open attitude to combat Antimicrobial resistance (AMR).

More information and free-of-charge registration
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!